class=”imagewrap has-source-dimensions”
data-crop-type=”wide”
style=”
–source-width: 4101;
–source-height: 2306;
”
>

Results from a Phase III trial show the Oxford AstraZeneca COVID-19 vaccine can be 79% effective at preventing symptoms of COVID-19.

Finnbarr Webster/Getty Images

hide caption

toggle caption

Finnbarr Webster/Getty Images

The Coronavirus Crisis

AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says

Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.

European Scientists Zero In On AstraZeneca Blood Clot Link

–>

–>

–>

World
Mar 21

Republic of Congo polls open; candidate sick with COVID-19

By Associated Press

–>

Sen. Portman Urges Action ‘Right Away’ to Help ‘Overwhelmed’ Border Patrol According to to Sen. Rob Portman, R-Ohio, it’s not unreasonable for the Biden administration to ask for $4 billion over the next four years for Central America to help countries of origin keep their populace within their own borders.

class=”imagewrap has-source-dimensions”
data-crop-type=”wide”
style=”
–source-width: 3500;
–source-height: 1968;
”
>

Researchers say they may have found a reason for a rare blood clotting condition that has occurred in some people who received the AstraZeneca COVID-19 vaccine.

Anatolii Stepanov/AFP via Getty Images

hide caption

toggle caption

Anatolii Stepanov/AFP via Getty Images

Coronavirus Updates

European Scientists Zero In On AstraZeneca Blood Clot Link

A rare blood clotting condition has occurred in some people after receiving the AstraZeneca COVID-19 vaccine. If the new research is correct, it could mean that blood clots could be easily treated.

World
Mar 21

Oil giant Saudi Aramco sees 2020 profits drop to $49 billion

By Isabel Debre, Associated Press